ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Uveitis

Uveitis

(©PavelLPhotoVideo/Shutterstock.com)

Adalimumab for the treatment of noninfectious uveitis has advantages over no treatment or conventional treatment with steroid therapy.

©PavelLPhotoVideo/Shutterstock.com

In this story, we revisit the clinical trials that led to the approval of adalimumab for uveitis.

Adalimumab improves function and quality of life for patients with uveitis, shows a study presented at 2015 ACR/ARHP.

A new tool could help ophthalmologists who see uveitis collaborate in the early diagnosis of spondyloarthritis.

Reports in a pediatric ophthalmology journal reveal risk factors and best treatments for refractory/recurrent uveitis in JIA.

The tumor necrosis factor α antagonist infliximab has been used for treating patients with uveitis resistant to corticosteroids.

Subscribe to Uveitis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.